| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 1.24e-04 | 320 | 31 | 5 | GO:0001227 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 1.35e-04 | 326 | 31 | 5 | GO:0001217 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | 2.09e-04 | 1412 | 31 | 9 | GO:0000981 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1.38e-03 | 1459 | 31 | 8 | GO:0000977 | |
| GeneOntologyBiologicalProcess | regulation of neuron differentiation | 3.63e-05 | 255 | 31 | 5 | GO:0045664 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | 1.24e-04 | 1053 | 31 | 8 | GO:0000122 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | 1.52e-04 | 1399 | 31 | 9 | GO:0045892 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | 1.64e-04 | 1413 | 31 | 9 | GO:1902679 | |
| Domain | Znf_C2H2-like | 3.84e-06 | 796 | 31 | 9 | IPR015880 | |
| Domain | Znf_C2H2 | 4.21e-06 | 805 | 31 | 9 | IPR007087 | |
| Domain | ZnF_C2H2 | 4.34e-06 | 808 | 31 | 9 | SM00355 | |
| Domain | - | 1.10e-05 | 679 | 31 | 8 | 3.30.160.60 | |
| Domain | Znf_C2H2/integrase_DNA-bd | 1.29e-05 | 694 | 31 | 8 | IPR013087 | |
| Domain | ZINC_FINGER_C2H2_2 | 2.86e-05 | 775 | 31 | 8 | PS50157 | |
| Domain | ZINC_FINGER_C2H2_1 | 2.91e-05 | 777 | 31 | 8 | PS00028 | |
| Domain | zf-C2H2 | 1.13e-04 | 693 | 31 | 7 | PF00096 | |
| Domain | zf-C2H2_6 | 1.72e-03 | 314 | 31 | 4 | PF13912 | |
| Domain | WD40 | 8.90e-03 | 259 | 31 | 3 | PF00400 | |
| Domain | WD40 | 9.76e-03 | 268 | 31 | 3 | SM00320 | |
| Domain | WD40_repeat | 1.02e-02 | 272 | 31 | 3 | IPR001680 | |
| Domain | WD_REPEATS_1 | 1.08e-02 | 278 | 31 | 3 | PS00678 | |
| Domain | WD_REPEATS_2 | 1.09e-02 | 279 | 31 | 3 | PS50082 | |
| Domain | WD_REPEATS_REGION | 1.09e-02 | 279 | 31 | 3 | PS50294 | |
| Domain | WD40_repeat_dom | 1.29e-02 | 297 | 31 | 3 | IPR017986 | |
| Domain | Ion_trans_dom | 1.53e-02 | 114 | 31 | 2 | IPR005821 | |
| Domain | Ion_trans | 1.53e-02 | 114 | 31 | 2 | PF00520 | |
| Domain | Homeodomain-like | 1.73e-02 | 332 | 31 | 3 | IPR009057 | |
| Domain | - | 1.75e-02 | 333 | 31 | 3 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 1.77e-02 | 335 | 31 | 3 | IPR015943 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | 6.52e-08 | 908 | 31 | 9 | 19274049 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.39e-05 | 351 | 31 | 5 | 38297188 | |
| Pubmed | Endosomal trafficking defects alter neural progenitor proliferation and cause microcephaly. | 2.76e-05 | 9 | 31 | 2 | 35013230 | |
| Pubmed | Bhlhb5 and Prdm8 form a repressor complex involved in neuronal circuit assembly. | 2.76e-05 | 9 | 31 | 2 | 22284184 | |
| Pubmed | 3.22e-05 | 418 | 31 | 5 | 34709266 | ||
| Pubmed | 3.44e-05 | 10 | 31 | 2 | 27798144 | ||
| Pubmed | 3.44e-05 | 10 | 31 | 2 | 20215343 | ||
| Pubmed | 3.44e-05 | 10 | 31 | 2 | 36596698 | ||
| Pubmed | Linx mediates interaxonal interactions and formation of the internal capsule. | 4.21e-05 | 11 | 31 | 2 | 24930700 | |
| Pubmed | 4.21e-05 | 11 | 31 | 2 | 31816041 | ||
| Pubmed | USP25 contributes to defective neurogenesis and cognitive impairments. | 4.21e-05 | 11 | 31 | 2 | 37171286 | |
| Pubmed | 5.05e-05 | 12 | 31 | 2 | 25037921 | ||
| Pubmed | 5.05e-05 | 12 | 31 | 2 | 31116980 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 5.46e-05 | 774 | 31 | 6 | 15302935 | |
| Pubmed | 5.96e-05 | 13 | 31 | 2 | 30858607 | ||
| Pubmed | 5.96e-05 | 13 | 31 | 2 | 23283686 | ||
| Pubmed | GIGYF1 disruption associates with autism and impaired IGF-1R signaling. | 5.96e-05 | 13 | 31 | 2 | 35917186 | |
| Pubmed | 5.96e-05 | 13 | 31 | 2 | 25698753 | ||
| Pubmed | Cis-regulatory control of corticospinal system development and evolution. | 5.96e-05 | 13 | 31 | 2 | 22678282 | |
| Pubmed | 5.96e-05 | 13 | 31 | 2 | 18840685 | ||
| Pubmed | 6.95e-05 | 14 | 31 | 2 | 26138486 | ||
| Pubmed | 6.95e-05 | 14 | 31 | 2 | 32518258 | ||
| Pubmed | Formation and function of the meningeal arachnoid barrier around the developing mouse brain. | 6.95e-05 | 14 | 31 | 2 | 36996816 | |
| Pubmed | FOXG1 sequentially orchestrates subtype specification of postmitotic cortical projection neurons. | 6.95e-05 | 14 | 31 | 2 | 35613274 | |
| Pubmed | 8.02e-05 | 15 | 31 | 2 | 23523356 | ||
| Pubmed | 8.02e-05 | 15 | 31 | 2 | 22723706 | ||
| Pubmed | Filamin A- and formin 2-dependent endocytosis regulates proliferation via the canonical Wnt pathway. | 9.16e-05 | 16 | 31 | 2 | 27789627 | |
| Pubmed | 9.16e-05 | 16 | 31 | 2 | 24875059 | ||
| Pubmed | 9.16e-05 | 16 | 31 | 2 | 25641781 | ||
| Pubmed | 9.16e-05 | 16 | 31 | 2 | 25196150 | ||
| Pubmed | 1.04e-04 | 17 | 31 | 2 | 34184027 | ||
| Pubmed | ASPM regulates symmetric stem cell division by tuning Cyclin E ubiquitination. | 1.04e-04 | 17 | 31 | 2 | 26581405 | |
| Pubmed | 1.17e-04 | 18 | 31 | 2 | 28272472 | ||
| Pubmed | 1.17e-04 | 18 | 31 | 2 | 27320921 | ||
| Pubmed | 1.17e-04 | 18 | 31 | 2 | 35930666 | ||
| Pubmed | Transcriptional repression by FEZF2 restricts alternative identities of cortical projection neurons. | 1.17e-04 | 18 | 31 | 2 | 34161768 | |
| Pubmed | Snf2l regulates Foxg1-dependent progenitor cell expansion in the developing brain. | 1.17e-04 | 18 | 31 | 2 | 22516202 | |
| Pubmed | 1.30e-04 | 19 | 31 | 2 | 33046550 | ||
| Pubmed | Pathfinding of corticothalamic axons relies on a rendezvous with thalamic projections. | 1.30e-04 | 19 | 31 | 2 | 23395374 | |
| Pubmed | 1.30e-04 | 19 | 31 | 2 | 37561632 | ||
| Pubmed | 1.60e-04 | 21 | 31 | 2 | 19686682 | ||
| Pubmed | Bcl11a (Ctip1) Controls Migration of Cortical Projection Neurons through Regulation of Sema3c. | 1.76e-04 | 22 | 31 | 2 | 26182416 | |
| Pubmed | 1.76e-04 | 22 | 31 | 2 | 20506362 | ||
| Pubmed | 1.76e-04 | 22 | 31 | 2 | 24453338 | ||
| Pubmed | FGF signaling expands embryonic cortical surface area by regulating Notch-dependent neurogenesis. | 1.76e-04 | 22 | 31 | 2 | 22031906 | |
| Pubmed | 1.76e-04 | 22 | 31 | 2 | 27117402 | ||
| Pubmed | Lhx2 regulates the timing of β-catenin-dependent cortical neurogenesis. | 1.92e-04 | 23 | 31 | 2 | 26371318 | |
| Pubmed | Rack1 is essential for corticogenesis by preventing p21-dependent senescence in neural stem cells. | 2.47e-04 | 26 | 31 | 2 | 34469723 | |
| Pubmed | Regulator-driven functional diversification of protein phosphatase-1 in eukaryotic evolution. | 2.47e-04 | 26 | 31 | 2 | 11948623 | |
| Pubmed | 2.66e-04 | 27 | 31 | 2 | 28768199 | ||
| Pubmed | 2.81e-04 | 143 | 31 | 3 | 20424473 | ||
| Pubmed | NPAS1 represses the generation of specific subtypes of cortical interneurons. | 3.08e-04 | 29 | 31 | 2 | 25467980 | |
| Pubmed | Nuclear receptor TLX prevents retinal dystrophy and recruits the corepressor atrophin1. | 3.52e-04 | 31 | 31 | 2 | 16702404 | |
| Pubmed | 3.52e-04 | 31 | 31 | 2 | 27321927 | ||
| Pubmed | 3.75e-04 | 32 | 31 | 2 | 31315048 | ||
| Pubmed | The transcription factor Otx2 regulates choroid plexus development and function. | 3.99e-04 | 33 | 31 | 2 | 23364326 | |
| Pubmed | 3.99e-04 | 33 | 31 | 2 | 30914320 | ||
| Pubmed | 3.99e-04 | 33 | 31 | 2 | 30037926 | ||
| Pubmed | 3.99e-04 | 33 | 31 | 2 | 23718855 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 4.16e-04 | 398 | 31 | 4 | 35016035 | |
| Pubmed | 4.49e-04 | 35 | 31 | 2 | 28808228 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 4.51e-04 | 736 | 31 | 5 | 29676528 | |
| Pubmed | The genetic architecture of economic and political preferences. | 5.02e-04 | 37 | 31 | 2 | 22566634 | |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 5.30e-04 | 38 | 31 | 2 | 30786075 | |
| Pubmed | 5.30e-04 | 38 | 31 | 2 | 34059773 | ||
| Pubmed | 6.17e-04 | 41 | 31 | 2 | 25452572 | ||
| Pubmed | 6.25e-04 | 188 | 31 | 3 | 29721183 | ||
| Pubmed | 7.43e-04 | 45 | 31 | 2 | 19877281 | ||
| Pubmed | Yin Yang 1 sustains biosynthetic demands during brain development in a stage-specific manner. | 8.11e-04 | 47 | 31 | 2 | 31097699 | |
| Interaction | RPL23AP32 interactions | 9.33e-06 | 87 | 31 | 4 | int:RPL23AP32 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.47e-04 | 15 | 22 | 2 | 529 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.66e-04 | 718 | 22 | 6 | 28 | |
| GeneFamily | WD repeat domain containing | 3.78e-03 | 262 | 22 | 3 | 362 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 1.14e-02 | 134 | 22 | 2 | 861 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.02e-02 | 181 | 22 | 2 | 694 | |
| Coexpression | GSE20727_H2O2_VS_ROS_INHIBITOR_TREATED_DC_UP | 3.47e-06 | 199 | 31 | 5 | M9255 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.56e-06 | 176 | 31 | 4 | e4b21fd6a5e0c5950f27c3e1868318e48330ae5e | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.70e-06 | 177 | 31 | 4 | bde307e67ad8e48a5ff4c0827015f4688f6b3e46 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 7.65e-06 | 183 | 31 | 4 | 310ad42b2b5d8ddd01d3a12db338f80ac1f5d08e | |
| ToppCell | 3'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.82e-06 | 195 | 31 | 4 | 6a0460d949ccda7c9fe76870d3ee6c2f60677d61 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD4-T_reg|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.06e-05 | 199 | 31 | 4 | 3f4907fa6d81c5691c19e6798145e9f9eccdfd20 | |
| ToppCell | Neuronal-Excitatory-eD(FEZF2)-ABO---L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.09e-05 | 200 | 31 | 4 | 7b845aabfbdfe893acc9334a5707833761bed60b | |
| ToppCell | Neuronal-Excitatory-eD(FEZF2)-ABO-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.09e-05 | 200 | 31 | 4 | e3051dcf9b5c8e4dc71a8080b7a7aafea46f2b2b | |
| ToppCell | Neuronal-Excitatory-eD(FEZF2)-ABO|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.09e-05 | 200 | 31 | 4 | 0638273fc0910f47fe7a0b6d9a8639b0e9976d13 | |
| ToppCell | Neuronal-Excitatory-eD(FEZF2)-ABO--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.09e-05 | 200 | 31 | 4 | 1ce9599cc9d8158e8842ca56f35fa7809c234849 | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-dn_T|Int-URO / Disease, condition lineage and cell class | 1.09e-05 | 200 | 31 | 4 | 020439d9e70fff7246650ab0e9105236688c3ec3 | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.04e-04 | 132 | 31 | 3 | 02491930097b75aaeedab9e8200711b0dc610944 | |
| ToppCell | Children_(3_yrs)-Immune-mast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.74e-04 | 157 | 31 | 3 | ec185dbeabb67fd9ca85f71cab88463b60f9b1c1 | |
| ToppCell | facs-Marrow-T-cells-24m-Hematologic-MPP_Fraction_B|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-04 | 160 | 31 | 3 | b3f7ef7e682b48a83ca425f5c439336e96168300 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.88e-04 | 161 | 31 | 3 | 580153e131247e6ec12a1a920f050a0a763e7e87 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.09e-04 | 167 | 31 | 3 | 83969c36ac44b96afc9aa09400a99fa2b487f7ff | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.13e-04 | 168 | 31 | 3 | 7abaddbcc55e44653d54aa15464266aa6bd5c9d2 | |
| ToppCell | COVID-19_Moderate-Treg|World / disease group, cell group and cell class | 2.17e-04 | 169 | 31 | 3 | 27ad11239559b025bef582f89b2a83501d9d3993 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.24e-04 | 171 | 31 | 3 | fe0665c5ca01b0b2cc8f20d64587f0847c3d215c | |
| ToppCell | Int-URO-Lymphocyte-T_NK-dnT|Int-URO / Disease, Lineage and Cell Type | 2.28e-04 | 172 | 31 | 3 | e70299573da1679d6d286c3a43699cbff76e207d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.32e-04 | 173 | 31 | 3 | 95c723b09254ae7131fe5ba0841472502e83269b | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.36e-04 | 174 | 31 | 3 | 321c6cae614d28feeee266eeb3499f2053ab79e0 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L5-6_FEZF2_ANKRD20A1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.36e-04 | 174 | 31 | 3 | 99eb5e1aee136c7039e23b68a43a0fa3d775859f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.40e-04 | 175 | 31 | 3 | 90e29945aa861082c94bb4f331161adc3a6ef899 | |
| ToppCell | metastatic_Brain-T/NK_cells-Exhausted_Tfh|metastatic_Brain / Location, Cell class and cell subclass | 2.40e-04 | 175 | 31 | 3 | b732c6a423c28856211002107d8c611dcfb6f265 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.44e-04 | 176 | 31 | 3 | 72a2a01618ce836bc843395d5095e9090759b4a6 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.48e-04 | 177 | 31 | 3 | 4c069f0d044a96118090b85ca592a21d6b5d9399 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L5-6_FEZF2_ANKRD20A1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.48e-04 | 177 | 31 | 3 | f63b62bb2be737f2d26be16943487ec27bf3bcd4 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.52e-04 | 178 | 31 | 3 | 431e7557b8e8764e16e9e48368ce6bfa3c61561a | |
| ToppCell | E17.5-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell_of_alveolus|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.52e-04 | 178 | 31 | 3 | 982205ba117a4c7b7e9b713689a5b69190f0bca9 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.56e-04 | 179 | 31 | 3 | 7954c0026754ab869b88ab7feb13c2f27d6e272d | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.56e-04 | 179 | 31 | 3 | f65889bf1e41396979cce44a5e63f49dea2bbd9b | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-04 | 180 | 31 | 3 | be10fe5bf7c3a671c42704ce7dd8226ab6896794 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.61e-04 | 180 | 31 | 3 | b514c55e52b46e8a1a2f09ed2c59a7683367a505 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-04 | 180 | 31 | 3 | 3b747a517ce75ef2ff09011c037dad7b01ed3e03 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.65e-04 | 181 | 31 | 3 | 08f44323bf71b6004a921bbc969c954c75feeb66 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-04 | 181 | 31 | 3 | 7af469f5bcb9b1ab3f35b2758bf2afb87e8eba57 | |
| ToppCell | Control-Myeloid-DC1|Control / Condition, Lineage and Cell class | 2.65e-04 | 181 | 31 | 3 | 5a2a1f017ad23baed9972c68b4a46f4c618ef21a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.65e-04 | 181 | 31 | 3 | 22363c5835dd6cef8f895ab9362e0837d92b15b1 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-04 | 182 | 31 | 3 | d41ff834b8fc1d0e23cac7ae261de5f72874e462 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-04 | 182 | 31 | 3 | 6cde859edfe7607bd7ada89d20258413d06f4207 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_3|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.74e-04 | 183 | 31 | 3 | 228092290dbb08785c4eda224e3ad03e99e10fab | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.74e-04 | 183 | 31 | 3 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.74e-04 | 183 | 31 | 3 | 65f2a5895d166189a095cf7ea9dda171f0419b08 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.74e-04 | 183 | 31 | 3 | fef51dcf180e6d4e136362c7e140ec5ef372e6d0 | |
| ToppCell | Control-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | 2.78e-04 | 184 | 31 | 3 | c6affa0b12510363258f65e46bf2d47bf4a8e75f | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.82e-04 | 185 | 31 | 3 | 02cbf492bc40abebaa93a3a208888afae72fbe06 | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-hematologic-hematopoietic_progenitor-common_myeloid_progenitor|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.82e-04 | 185 | 31 | 3 | eac18ddcdac60b829619f7657e833d08cc9bcbab | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.82e-04 | 185 | 31 | 3 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.82e-04 | 185 | 31 | 3 | 1b8e3ddb91797f84e4b15d2457b0c008e5be50db | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.92e-04 | 187 | 31 | 3 | e35716f8b482be3bf5ab79f087a9caf67a9d197a | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.96e-04 | 188 | 31 | 3 | 72be6fe654f3a5f654d3b9680145bce7ae9b721d | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.96e-04 | 188 | 31 | 3 | 9db3d3010cb8a1f3ee1cdccaf3cbaac3cf983fc5 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.96e-04 | 188 | 31 | 3 | f54b063025d80de631382bf5326bc40aab7f7d00 | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-Treg|COVID-19_Mild / Disease group, lineage and cell class | 2.96e-04 | 188 | 31 | 3 | 42553fdc127e5f613ffd5067620a768a40f1a8a1 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.96e-04 | 188 | 31 | 3 | d8decd9b5967873ca8320c2f9f07365f163c777f | |
| ToppCell | nucseq-Immune-Immune_Myeloid-Myeloid_Dendritic-cDC1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.96e-04 | 188 | 31 | 3 | d5ce3ffe783c322b4765b790e861727e46bc34b3 | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.01e-04 | 189 | 31 | 3 | df30478b288084a1bd48f660409dcc784040897c | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-hematopoietic_progenitor-common_myeloid_progenitor|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.01e-04 | 189 | 31 | 3 | 56156325cc36b1329bf483f81bb74f371ef15e20 | |
| ToppCell | Control-Lymphoid-T_Cytotoxic|World / Disease state, Lineage and Cell class | 3.01e-04 | 189 | 31 | 3 | ee4c1d930534788a7759d92dc8ff9c62e6ee2301 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.05e-04 | 190 | 31 | 3 | 938d1f66094b1c94606e0d40213a39e5112f3322 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.05e-04 | 190 | 31 | 3 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | IPF-Lymphoid-T|IPF / Disease state, Lineage and Cell class | 3.05e-04 | 190 | 31 | 3 | d57df208aaf7a5554899bb9107c80b443fd0cf93 | |
| ToppCell | Control-Lymphoid-T_Cytotoxic|Control / Disease state, Lineage and Cell class | 3.10e-04 | 191 | 31 | 3 | 03b5c5e0941c3402ab3f48cbf3da2a027d110421 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.10e-04 | 191 | 31 | 3 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.10e-04 | 191 | 31 | 3 | c7be771543089fc94e5c62fd22f745189642aec3 | |
| ToppCell | Adult-Immune-T_lymphocyte-D175|Adult / Lineage, Cell type, age group and donor | 3.10e-04 | 191 | 31 | 3 | 0b84fd1dc68146d9f72422b102744d2847f5ecb2 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.10e-04 | 191 | 31 | 3 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.10e-04 | 191 | 31 | 3 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | COPD-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | 3.10e-04 | 191 | 31 | 3 | 3480e6d27dd4291765bbbb2acdb6a2e4f02c8085 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.15e-04 | 192 | 31 | 3 | 446c61c0d6ba89c619efe87ee495951299953981 | |
| ToppCell | COPD-Lymphoid|COPD / Disease state, Lineage and Cell class | 3.15e-04 | 192 | 31 | 3 | 064fefb8212fadab0ff441f4bf643559b7fdb25d | |
| ToppCell | Control-Lymphoid-T|World / Disease state, Lineage and Cell class | 3.15e-04 | 192 | 31 | 3 | 253cf4d2cf88ad8c45b73779336180840bef054b | |
| ToppCell | COPD-Lymphoid-T|World / Disease state, Lineage and Cell class | 3.15e-04 | 192 | 31 | 3 | eb4909574fb5fc91399463523e2737095773200a | |
| ToppCell | IPF-Lymphoid-T|World / Disease state, Lineage and Cell class | 3.15e-04 | 192 | 31 | 3 | b25ba1f3bc842c22602b2aeed3b1b5082863e4fa | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.15e-04 | 192 | 31 | 3 | c0e59e642b42c055cf73d029cf54d07d9b719359 | |
| ToppCell | normal-na-Lymphocytic_B-B_cell-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.20e-04 | 193 | 31 | 3 | 4fbf559771c367a6f5a03e0a5ef33366c118ddbf | |
| ToppCell | IPF-Lymphoid|IPF / Disease state, Lineage and Cell class | 3.20e-04 | 193 | 31 | 3 | bf9d50aea909a28dd1d0933af33842d5f1ae7818 | |
| ToppCell | Adult-Immune-T_lymphocyte|Adult / Lineage, Cell type, age group and donor | 3.20e-04 | 193 | 31 | 3 | 26df0c4c8a2355dd5503fadd07e368eb9a2bf06a | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.20e-04 | 193 | 31 | 3 | b7c0b4dbbe11f86cff6371d3d12a6b772b938d78 | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.20e-04 | 193 | 31 | 3 | e44d777f65b907f299cefd73296805ac4c92d383 | |
| ToppCell | normal-na-Lymphocytic_B-B_cell|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.20e-04 | 193 | 31 | 3 | 2fd1cc050c775360cd53872fd405cf78288d7c4d | |
| ToppCell | Control-Lymphoid-T|Control / Disease state, Lineage and Cell class | 3.20e-04 | 193 | 31 | 3 | af928046ccd1ca874be1534aef6ca7f27d90bc46 | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-CD4_T|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.20e-04 | 193 | 31 | 3 | 9c9434a3297b85774b4f0ecab6294f44d738e29f | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.20e-04 | 193 | 31 | 3 | 9ba688b35a9ead5d04691b3f3f15484f02dbbd0d | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.20e-04 | 193 | 31 | 3 | b9769b45125d2244afe53f9f71c92c04ddccf980 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.20e-04 | 193 | 31 | 3 | 52e918884877b6659cdca0496390e440f73694a9 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 3.20e-04 | 193 | 31 | 3 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | erythropoietic-CD34+_Pro-erythroblast|World / Lineage and Cell class | 3.25e-04 | 194 | 31 | 3 | cd12d01f6f2f12bbc33ed523bc678d3965074974 | |
| ToppCell | Endothelial-endothelial_cell_of_vein|World / Lineage, Cell type, age group and donor | 3.25e-04 | 194 | 31 | 3 | 3cbd9622a68e89add90e589867d88c83c5a33476 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.25e-04 | 194 | 31 | 3 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | Control-Lymphoid|Control / Disease state, Lineage and Cell class | 3.25e-04 | 194 | 31 | 3 | d5b124f15c953eeb7e8e990df44d7fa466f2b31f | |
| ToppCell | Adult-Immune-T_lymphocyte-D231|Adult / Lineage, Cell type, age group and donor | 3.25e-04 | 194 | 31 | 3 | 5c1dca33f382f37a7deb23e573578343c3b54986 | |
| ToppCell | normal_Lung-Myeloid_cells-CD141+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 3.25e-04 | 194 | 31 | 3 | d21461682fa755f588afe073abb6a777f339c4cc | |
| ToppCell | Immune-T_lymphocyte|World / Lineage, Cell type, age group and donor | 3.25e-04 | 194 | 31 | 3 | f47fa18c87b35a3960557f8169ff7830dd6ecb80 | |
| ToppCell | Influenza_Severe-B_naive|Influenza_Severe / Disease group and Cell class | 3.30e-04 | 195 | 31 | 3 | a25516ed670c7738670ffbaa6f7cd167946f3825 | |
| ToppCell | proximal-Hematologic-Natural_Killer_T-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.30e-04 | 195 | 31 | 3 | 4d7c2c4d0130c2d46877ff6dd4584525d8f74daf | |
| ToppCell | proximal-3-Hematologic-Natural_Killer_T|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.30e-04 | 195 | 31 | 3 | 93093545bb23d2619ace029a52cffa1f673a0c2a | |
| ToppCell | Control-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 3.30e-04 | 195 | 31 | 3 | 6687e579582d7a239bee80846de0cf827a6f6a62 | |
| ToppCell | proximal-Hematologic-Natural_Killer_T|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.30e-04 | 195 | 31 | 3 | 3944e4800f5d904d4efa401ce8913ec0e0781211 | |
| ToppCell | mild_COVID-19_(asymptomatic)-B_naive|World / disease group, cell group and cell class (v2) | 3.30e-04 | 195 | 31 | 3 | e763d9a431052c03cc6d514f2736506c6667e2be | |
| Drug | clozapine; Up 200; 10uM; MCF7; HT_HG-U133A | 2.39e-07 | 197 | 31 | 6 | 6947_UP | |
| Drug | czp | 1.84e-06 | 18 | 31 | 3 | CID005288014 | |
| Drug | 2-methoxyidazoxan | 1.07e-05 | 4 | 31 | 2 | ctd:C058525 | |
| Disease | microcephaly (implicated_via_orthology) | 5.10e-06 | 32 | 31 | 3 | DOID:10907 (implicated_via_orthology) | |
| Disease | Intellectual Disability | 9.58e-05 | 447 | 31 | 5 | C3714756 | |
| Disease | Uterine leiomyoma, estrogen-receptor positive breast cancer | 1.62e-04 | 18 | 31 | 2 | EFO_1000649, HP_0000131 | |
| Disease | trans fatty acid measurement, trans/trans-18:2 fatty acid measurement | 2.91e-04 | 24 | 31 | 2 | EFO_0006821, EFO_0006826 | |
| Disease | Postural instability | 3.16e-04 | 25 | 31 | 2 | HP_0002172 | |
| Disease | Uterine leiomyoma, breast carcinoma | 5.20e-04 | 32 | 31 | 2 | EFO_0000305, HP_0000131 | |
| Disease | Thyroid Gland Follicular Adenoma | 6.22e-04 | 35 | 31 | 2 | C0151468 | |
| Disease | Thyroid Neoplasm | 6.95e-04 | 37 | 31 | 2 | C0040136 | |
| Disease | Thyroid carcinoma | 9.83e-04 | 44 | 31 | 2 | C0549473 | |
| Disease | Endometrial Neoplasms | 1.70e-03 | 58 | 31 | 2 | C0014170 | |
| Disease | PR interval | 1.72e-03 | 495 | 31 | 4 | EFO_0004462 | |
| Disease | multiple myeloma (is_implicated_in) | 1.76e-03 | 59 | 31 | 2 | DOID:9538 (is_implicated_in) | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 1.88e-03 | 61 | 31 | 2 | DOID:3587 (is_marker_for) | |
| Disease | basophil count, eosinophil count | 2.04e-03 | 241 | 31 | 3 | EFO_0004842, EFO_0005090 | |
| Disease | Microcephaly | 2.26e-03 | 67 | 31 | 2 | C0025958 | |
| Disease | renal cell carcinoma (is_implicated_in) | 2.40e-03 | 69 | 31 | 2 | DOID:4450 (is_implicated_in) | |
| Disease | Endometrial Carcinoma | 2.61e-03 | 72 | 31 | 2 | C0476089 | |
| Disease | Amphetamine-Related Disorders | 2.83e-03 | 75 | 31 | 2 | C0236733 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DEDPEEEEDKECTLE | 1291 | Q5RHP9 | |
| DGEEEEEEEEPLDES | 66 | Q8WYA6 | |
| KCSPEEDEEDEEDVD | 351 | Q8IUR6 | |
| GPEEEEEEEEEDEEG | 296 | Q9H116 | |
| EEEEEEEEECEPQAV | 301 | P18089 | |
| CEEEEEEEEDDPGDI | 21 | O95376 | |
| AEEEEEEEEEVDLAC | 271 | P24385 | |
| ETPILDDYDCEEDEE | 286 | O75129 | |
| DEDSEERELPEEEEI | 381 | Q2M243 | |
| EEEEEEEEEESLPGC | 716 | Q9Y4C8 | |
| LEDAIEDEEEECPSE | 16 | Q8WW38 | |
| EDEEEECPSEETDII | 21 | Q8WW38 | |
| LEDTKDDPECGVEEE | 161 | Q8N8A8 | |
| SDDDEEEEENIGCEE | 451 | Q9H3P7 | |
| EAPVECEEEEEVEEE | 366 | P24394 | |
| LGHEPEEEDEEEEEE | 526 | Q9C0K0 | |
| RFEEGDPEEEECEVD | 56 | Q96RJ6 | |
| DPEEEECEVDQGDGE | 61 | Q96RJ6 | |
| PAEVVVCLDEEEEEE | 506 | Q8IX15 | |
| VCLDEEEEEEEEELP | 511 | Q8IX15 | |
| LDVCGEEEDDEEEED | 136 | Q9BUN5 | |
| CDVPVGEEEEEEEED | 821 | Q01668 | |
| CEVNDLGEEEEEEEE | 261 | Q13029 | |
| EEEEEEDGLSEECEE | 81 | Q96PZ0 | |
| EEDEDEDEDVSDICI | 196 | Q9Y330 | |
| HCGVPLEEEEEEEED | 1906 | Q15413 | |
| EDGDEGEEEEEACPE | 86 | Q6ZSY5 | |
| PSQEDKEDEDEDEEC | 496 | Q9BWH6 | |
| CEKPQGDEEEEEEEE | 1056 | P37275 | |
| EQTEDDLEEECEPEE | 796 | O43379 | |
| EDEVECSDKDEPDLD | 246 | Q9Y2I8 | |
| GSECDPDQEEEEEEE | 21 | A6NFI3 | |
| EDIDSDEELECEDTE | 211 | Q969S3 | |
| EEEEDSCVVLEEEEG | 1156 | Q562E7 | |
| DCVTSEEEEELEEEE | 951 | Q96PN7 |